234 related articles for article (PubMed ID: 30207742)
1. Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
de Sousa Cunha F; Dos Santos Pereira LN; de Costa E Silva TP; de Sousa Luz RA; Nogueira Mendes A
J Drug Target; 2019 Aug; 27(7):732-741. PubMed ID: 30207742
[TBL] [Abstract][Full Text] [Related]
2. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
3. Loco-regional administration of nanomedicines for the treatment of lung cancer.
Garrastazu Pereira G; Lawson AJ; Buttini F; Sonvico F
Drug Deliv; 2016 Oct; 23(8):2881-2896. PubMed ID: 26585837
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer.
Yang J; Lee CH; Ko HJ; Suh JS; Yoon HG; Lee K; Huh YM; Haam S
Angew Chem Int Ed Engl; 2007; 46(46):8836-9. PubMed ID: 17943947
[No Abstract] [Full Text] [Related]
5. Liposomal nanomedicine for breast cancer therapy.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
[TBL] [Abstract][Full Text] [Related]
6. Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety.
Morsink M; Parente L; Silva F; Abrantes A; Ramos A; Primo I; Willemen N; Sanchez-Lopez E; Severino P; Souto EB
Curr Pharm Des; 2022; 28(2):104-115. PubMed ID: 34348617
[TBL] [Abstract][Full Text] [Related]
7. Nanooncology in ovarian cancer treatment.
Kasprzak B; Miskiel S; Markowska J
Eur J Gynaecol Oncol; 2016; 37(2):161-3. PubMed ID: 27172737
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for diagnosis and targeting of breast cancer.
Sharma A; Jain N; Sareen R
Biomed Res Int; 2013; 2013():960821. PubMed ID: 23865076
[TBL] [Abstract][Full Text] [Related]
9. Applications of nanomedicine in breast cancer detection, imaging, and therapy.
Saadeh Y; Leung T; Vyas A; Chaturvedi LS; Perumal O; Vyas D
J Nanosci Nanotechnol; 2014 Jan; 14(1):913-23. PubMed ID: 24730308
[TBL] [Abstract][Full Text] [Related]
10. Inorganic nanoparticles for predictive oncology of breast cancer.
Yezhelyev M; Yacoub R; O'Regan R
Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for microRNA delivery in cancer medicine.
Fernandez-Piñeiro I; Badiola I; Sanchez A
Biotechnol Adv; 2017; 35(3):350-360. PubMed ID: 28286148
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
14. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
15. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
16. Surface engineered nanocarriers for the management of breast cancer.
Nitheesh Y; Pradhan R; Hejmady S; Taliyan R; Singhvi G; Alexander A; Kesharwani P; Dubey SK
Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112441. PubMed ID: 34702526
[TBL] [Abstract][Full Text] [Related]
17. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
18. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
[TBL] [Abstract][Full Text] [Related]
20. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
